Takanori Ito Selected Research

Takanori Ito Research Topics

Disease

27	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 12/2012
16	Neoplasms (Cancer) 01/2022 - 12/2012
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 10/2015
8	Infections 01/2022 - 07/2015
7	Fibrosis (Cirrhosis) 04/2022 - 03/2014
6	Inflammation (Inflammations) 04/2022 - 10/2016
6	Non-alcoholic Fatty Liver Disease 04/2022 - 01/2017
5	Hemorrhage 10/2021 - 02/2019
4	Liver Diseases (Liver Disease) 01/2022 - 03/2019
4	Chronic Hepatitis B 12/2021 - 07/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2021
3	Hepatitis 01/2022 - 12/2012
3	Hepatitis C 03/2021 - 03/2014
2	Varicose Veins (Varicose Vein) 12/2022 - 10/2021
2	Diarrhea 03/2022 - 02/2020
2	Hemophilia A (Haemophilia) 01/2022 - 01/2021
2	Chronic Hepatitis C 12/2021 - 07/2015
2	Alcoholic Fatty Liver 11/2021 - 01/2021
2	Insulin Resistance 10/2021 - 01/2020
2	Hepatitis B 01/2021 - 07/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 09/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2020
2	Carcinoma (Carcinomatosis) 09/2020 - 06/2013
2	Fever (Fevers) 06/2020 - 10/2019
2	Pemphigus (Pemphigus Vulgaris) 01/2019 - 06/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022
1	Diabetes Mellitus 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Fatty Liver 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Pneumonia (Pneumonitis) 12/2021
1	Metabolic Diseases (Metabolic Disease) 10/2021
1	Portal Hypertension 10/2021

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2015
7	Sorafenib (BAY 43-9006)FDA Link 06/2020 - 12/2012
5	lenvatinibIBA 03/2022 - 03/2020
4	Immune Checkpoint InhibitorsIBA 02/2022 - 06/2020
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 12/2012
3	BilirubinIBA 08/2021 - 01/2019
3	Pemetrexed (MTA)FDA Link 08/2021 - 03/2021
3	Branched-Chain Amino AcidsIBA 01/2020 - 03/2014
3	lentil lectinIBA 07/2015 - 12/2012
2	Choline (Choline Chloride)IBA 04/2022 - 11/2021
2	Amino Acids FDA Link 01/2022 - 01/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 12/2021
2	Hepatitis B e AntigensIBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 11/2021 - 10/2021
2	AlbuminsIBA 08/2021 - 03/2021
2	Conditioned Culture MediaIBA 01/2021 - 10/2016
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2019
2	Indicators and Reagents (Reagents)IBA 01/2021 - 04/2020
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2021 - 10/2016
2	Cytidine Triphosphate (CTP)IBA 09/2020 - 07/2020
2	RamucirumabIBA 04/2020 - 09/2019
2	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	telomerase RNA (bTR)IBA 01/2020 - 01/2020
2	ZincIBA 01/2020 - 01/2020
2	regorafenibIBA 10/2019 - 09/2019
2	perfluorobutane (AI 700)IBA 12/2015 - 09/2014
2	GadoliniumIBA 01/2015 - 06/2013
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2015 - 06/2013
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2015 - 06/2013
2	Tumor Biomarkers (Tumor Markers)IBA 06/2014 - 12/2012
2	acarboxyprothrombin (PIVKA)IBA 06/2014 - 12/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2013 - 12/2012
1	Sclerosing Solutions (Sclerosing Agents)IBA 12/2022
1	Keratin-5 (Keratin 5)IBA 10/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2022
1	astaxanthine (astaxanthin)IBA 04/2022
1	Estrogens (Estrogen)FDA Link 04/2022
1	OsteoprotegerinIBA 04/2022
1	Butyrates (Butyrate)IBA 03/2022
1	Hair DyesIBA 01/2022
1	AntigensIBA 01/2022
1	FumaratesIBA 12/2021
1	entecavir FDA Link 12/2021
1	tenofovir alafenamideIBA 12/2021
1	NivolumabIBA 12/2021
1	pembrolizumabIBA 12/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 11/2021
1	EmulsionsIBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	Pyruvic Acid (Pyruvate)IBA 10/2021
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 10/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021

Therapy/Procedure

18	Therapeutics 12/2022 - 01/2012
3	Aftercare (After-Treatment) 01/2022 - 12/2012
3	Liver Transplantation 01/2021 - 07/2020
3	Drug Therapy (Chemotherapy) 09/2020 - 06/2013
3	Hepatectomy 07/2015 - 12/2012
2	Ligation 10/2021 - 02/2019
2	Immunotherapy 01/2021 - 09/2020
2	Intravenous Administration 01/2021 - 10/2016
1	Sclerotherapy 12/2022
1	Transurethral Resection of Bladder 10/2022
1	Bathroom Equipment 01/2022
1	Cesarean Section (Caesarean Section) 01/2022
1	Time-to-Treatment 01/2022